We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$14.7B
AUM Growth
+$562M
Cap. Flow
-$182M
Cap. Flow %
-1.24%
Top 10 Hldgs %
20.54%
Holding
1,679
New
173
Increased
492
Reduced
677
Closed
92

Top Buys

Rank Stock Value
1
P
Everpure Inc
P
+$58.5M
2
DOCU
DocuSign
DOCU
+$21.3M
3
BKE icon
Buckle
BKE
+$20.9M
4
MSFT icon
Microsoft
MSFT
+$18.4M
5
USFD icon
US Foods
USFD
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.16%
2 Healthcare 17.99%
3 Financials 13.41%
4 Industrials 9.72%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NID
1201
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
$244K ﹤0.01%
+19,620
New +$244K
ECON icon
1202
Columbia Emerging Markets Consumer ETF
ECON
$338M
$242K ﹤0.01%
9,915
FPI
1203
Farmland Partners
FPI
$425M
$241K ﹤0.01%
27,425
HCAP
1204
DELISTED
Harvest Capital Credit Corporation
HCAP
$241K ﹤0.01%
22,840
-1,550
-6% -$16K
GARS
1205
DELISTED
Garrison Capital Inc.
GARS
$240K ﹤0.01%
29,500
+1,000
+4% +$8.38K
WDC icon
1206
Western Digital
WDC
$189B
$239K ﹤0.01%
4,076
-782
-16% -$49.8K
DLTR icon
1207
Dollar Tree
DLTR
$25.1B
$238K ﹤0.01%
2,804
ASTE icon
1208
Astec Industries
ASTE
$1.2B
$237K ﹤0.01%
3,960
-755
-16% -$43.6K
AUTL
1209
Autolus Therapeutics
AUTL
$519M
$236K ﹤0.01%
+8,800
New +$233K
EWL icon
1210
iShares MSCI Switzerland ETF
EWL
$2.21B
$236K ﹤0.01%
7,233
-186
-3% -$6.29K
GL icon
1211
Globe Life
GL
$14.3B
$236K ﹤0.01%
2,900
SPIB icon
1212
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$235K ﹤0.01%
7,072
DOC
1213
DELISTED
PHYSICIANS REALTY TRUST
DOC
$235K ﹤0.01%
14,757
-1,058
-7% -$16K
VTWG icon
1214
Vanguard Russell 2000 Growth ETF
VTWG
$1.54B
$234K ﹤0.01%
1,580
AMRB
1215
DELISTED
American River Bankshares
AMRB
$234K ﹤0.01%
14,776
ACWX icon
1216
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
$233K ﹤0.01%
4,936
-5,656
-53% -$280K
LTC
1217
LTC Properties
LTC
$1.97B
$231K ﹤0.01%
+5,395
New +$211K
ACIW icon
1218
ACI Worldwide
ACIW
$5.82B
$230K ﹤0.01%
+9,339
New +$227K
ANIK icon
1219
Anika Therapeutics
ANIK
$262M
$230K ﹤0.01%
7,177
VT icon
1220
Vanguard Total World Stock ETF
VT
$79.4B
$230K ﹤0.01%
3,136
+54
+2% +$4.03K
AXTA icon
1221
Axalta
AXTA
$8.05B
$229K ﹤0.01%
7,560
-54,246
-88% -$1.7M
BNDX icon
1222
Vanguard Total International Bond ETF
BNDX
$82.3B
$229K ﹤0.01%
4,188
+73
+2% +$3.98K
ONC
1223
BeOne Medicines Ltd
ONC
$33.5B
$229K ﹤0.01%
1,490
+40
+3% +$7.13K
VCRA
1224
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$229K ﹤0.01%
+7,675
New +$204K
ASML icon
1225
ASML
ASML
$658B
$228K ﹤0.01%
1,150
-175
-13% -$35.1K

Similar funds

William Blair & Company's Q2 2018 Portfolio in Review

As of Q2 2018, William Blair & Company held 1,679 positions worth $14.7B, up 4% from $14.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

William Blair & Company's Q2 2018 filing shows 173 new, 492 increased, 677 reduced and 92 closed positions. Its largest new stake was DocuSign: 422,114 shares worth $22.4M. The largest sale was Starbucks, an estimated $47M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2018 buy was DocuSign: 422,114 shares worth $22.4M.
  • William Blair & Company added most to Everpure Inc in Q2 2018, an estimated $58.5M increase.
  • William Blair & Company's biggest Q2 2018 reduction was Starbucks, cutting an estimated $47M.
  • William Blair & Company fully exited Cavium, Inc. in Q2 2018, selling an estimated $9.64M.
  • William Blair & Company's ten largest holdings make up 21% of its $14.7B portfolio in Q2 2018.
  • William Blair & Company opened 173 new positions and closed 92 in Q2 2018.
  • William Blair & Company's portfolio value rose 4% quarter-over-quarter to $14.7B.

Based on William Blair & Company's 13F filing for Q2 2018, filed 13 Aug 2018.